• Stem cells and SCGF introduction—Presentation.
• Panel discussion:  between the stem cell experts and doctors
• Business models for successful stem cell companies and innovative funding mechanisms
• Leading Speakers from stem cell industry
• Leading Doctors from the Leading hospitals
• Awards ceremony
• Discussions and QA session

Stem cells are being developed for use as therapies for many diseases. They also have strong potential for use in drug discovery, finding applications in toxicology testing and understanding disease mechanisms for novel target identification. The potential for this research is huge, and companies need to arm themselves with essential scientific knowledge alongside the necessary business understanding in this field.

In SCGS-2009, the meeting was distinguished by the presence of a number of eminent personalities from the field, While many speakers, from both stem cell research and business backgrounds, were confident in the future use of stem cell technologies and therapies, they were also willing to admit the presence of a number of technical and political hindrances to the advancement of the discipline. This report focuses on use of stem cells as therapeutics and for predictive screens.

In SCGS-2010 the agenda reflects the dynamic nature of the field as we move from fundamental stem cell research towards clinical therapies. With a multidisciplinary range of speakers the meeting, sharing their experiences, views, ideas, truly encompasses "bench to bedside" stem cell research.

STEM CELL GLOBAL SYMPOSIUM-2009 was well attended, with over 100 delegates from diverse realms within industry and academia. The meeting covered a range of therapeutic areas of stem cell and regenerative medicine. Both lecture and panel session formats were used, as well as a novel 'speed-networking' approach for meeting delegates.

Now SCGS-2010 offers the most cutting-edge content in commercial stem cell use. Industry experts converge to debate and discuss how to overcome the challenges facing regenerative medicine industry today, to open opportunities and business development tomorrow. SCGS-2010 Stem Cells conference brings together leading pharmaceutical companies and smaller biotech's working in regenerative medicine to discuss the scientific advances and future business opportunities offered by stem cell research. Don't miss your chance to network with the leaders in this field, and look towards the future of this rapidly expanding area of medicine.

7 reasons to attend the SCGS- 2010 .

• Issues that matter. Participants who are not afraid to challenge the system.
• Interactive panel sessions actively solving the problems. Driven to get the results, not just talk about them.
• A speaker-list that reads like the industry Who's Who. Be at the event that all the experts want to speak at.
• Integration of both classes of stem cell application. The only congress to combine cell therapy with drug discovery in a brand new 2-stream format!
• More executive-level delegates than any other stem cell conference. With 100+ executive level attendees in 2009!
• Unique networking opportunities. Our innovative Speed Networking and Contact system offer a networking experience - before, during and after the event - like no other.